文献速递传染病防控与疫情报告卫生政策与健康促进

人类猴痘流行病学——全球,2018-2021年

Epidemiology of Human Mpox - Worldwide, 2018-2021.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2023-01-20

本报告描述了1970年以来及2018-2021年期间猴痘的流行病学,数据来自国家监测规划、世界卫生组织(WHO)公报和病例报告。2018-2021年期间,六个非洲国家发现并确认了人间病例,其中大多数在刚果民主共和国和尼日利亚检出;另有四例非洲以外国家患者在从尼日利亚旅行后被识别。

要点

  • 2018-2021年六个非洲国家确认人间猴痘病例,多数在刚果民主共和国和尼日利亚检出。
  • 非洲以外四国在患者从尼日利亚旅行后识别出八例猴痘病例。
  • 自2018年起,OpenWHO在线提供针对公共卫生和卫生保健提供者的猴痘预防控制培训课程。

核心结论

  • 猴痘在非洲重新出现且病例增加,2019年被列为WHO非洲区域通过综合疾病监测与应对策略进行立即和常规报告的优先疾病。
  • 2022年5月开始的全球暴发进一步凸显了改进实验室监测以及获取治疗和疫苗以预防和遏制感染的必要性,包括在猴痘地方性流行的非洲地区。

研究设计与样本

  • 本报告利用国家监测规划、世界卫生组织(WHO)公报和病例报告的数据,描述了1970年以来及2018-2021年期间猴痘的流行病学。

主要发现

  • 2018-2021年期间,六个非洲国家发现并确认了人间病例,其中大多数在刚果民主共和国和尼日利亚检出。
  • 非洲以外四个国家在患者从尼日利亚旅行后识别出八例猴痘病例。
  • 非洲每年的病例数自2014年以来上升,大多数国家累计超过此前40年的报告数。
  • 猴痘重新出现可能由环境与生态变化、动物或人类流动、1980年天花根除后常规天花疫苗接种停止、疾病检测和诊断改进以及病毒基因变化等因素共同导致。

关键数值与推荐

  • 猴痘由猴痘病毒(MPXV)引起,属于正痘病毒属,野生哺乳动物储存宿主尚不清楚。
  • MPXV有两个遗传分支:分支I和分支II,历史上分别发现于中非和西非,仅喀麦隆报告过两个分支。

临床怎么用

  • 自2018年起,OpenWHO在线提供针对公共卫生和卫生保健提供者的猴痘预防和控制入门及中级培训课程。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Monkeypox (mpox) is a zoonotic disease caused by Monkeypox virus (MPXV), an Orthopoxvirus; the wild mammalian reservoir species is not known. There are two genetic clades of MPXV: clade I and clade II (historically found in central and west Africa, respectively), with only Cameroon reporting both clades (1). Human cases have historically been reported from 1) mostly rural, forested areas in some central and west African countries; 2) countries reporting cases related to population migration or travel of infected persons; and 3) exposure to imported infected mammals (2). The annual number of cases in Africa has risen since 2014 and cumulatively surpassed reports from the previous 40 years for most countries. This reemergence of mpox might be due to a combination of environmental and ecological changes, animal or human movement, the cessation of routine smallpox vaccination since its eradication in 1980, improvements in disease detection and diagnosis, and genetic changes in the virus (2). This report describes the epidemiology of mpox since 1970 and during 2018-2021, using data from national surveillance programs, World Health Organization (WHO) bulletins, and case reports, and addresses current diagnostic and treatment challenges in countries with endemic disease. During 2018-2021, human cases were recognized and confirmed in six African countries, with most detected in the Democratic Republic of the Congo (DRC) and Nigeria. The reemergence and increase in cases resulted in its being listed in 2019 as a priority disease for immediate and routine reporting through the Integrated Disease Surveillance and Response strategy in the WHO African region.* In eight instances, patients with mpox were identified in four countries outside of Africa after travel from Nigeria. Since 2018, introductory and intermediate training courses on prevention and control of mpox for public health and health care providers have been available online at OpenWHO.†,§ The global outbreak that began in May 2022¶ has further highlighted the need for improvements in laboratory-based surveillance and access to treatments and vaccines to prevent and contain the infection, including in areas of Africa with endemic mpox.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. McCollum AM, Shelus V, Hill A, et al. Epidemiology of Human Mpox - Worldwide, 2018-2021. MMWR Morb Mortal Wkly Rep. 2023. PMID: 36656790. doi:10.15585/mmwr.mm7203a4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。